LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 152 filers reported holding LOXO ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,962,000 | -23.1% | 42,564 | -6.3% | 0.01% | -9.1% |
| Q3 2018 | $7,757,000 | +5.7% | 45,410 | +7.3% | 0.01% | 0.0% |
| Q2 2018 | $7,340,000 | +70.1% | 42,310 | +13.1% | 0.01% | +57.1% |
| Q1 2018 | $4,316,000 | +74.9% | 37,410 | +27.6% | 0.01% | +75.0% |
| Q4 2017 | $2,467,000 | +126.7% | 29,310 | +148.2% | 0.00% | +100.0% |
| Q3 2017 | $1,088,000 | +39.7% | 11,810 | +21.6% | 0.00% | +100.0% |
| Q2 2017 | $779,000 | – | 9,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,452,493 | $45,330,000 | 8.79% |
| BVF INC/IL | 1,192,202 | $15,654,000 | 3.25% |
| Redmile Group, LLC | 540,300 | $7,094,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,591,546 | $20,897,000 | 0.76% |
| Orbimed Advisors | 2,175,857 | $28,569,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 365,566 | $4,800,000 | 0.18% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 75,000 | $985,000 | 0.13% |
| RS INVESTMENT MANAGEMENT CO LLC | 599,400 | $7,870,000 | 0.07% |
| Visium Asset Management, LP | 332,516 | $4,366,000 | 0.06% |
| Nicholas Investment Partners, LP | 73,341 | $963,000 | 0.06% |